Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Rogers

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Psychosomatics|July 1, 1994
Development of obsessive-compulsive disorder after brain tumor surgery and radiationM P Rogers, A Y Mendoza
FEBS Letters|January 21, 1985
Reconstituted high density lipoprotein behaviour is modified by the nature of the lipid vesicleS M Jones, M P Rogers
Psychosomatic Medicine|March 1, 1979
The influence of the psyche and the brain on immunity and disease susceptibility: a critical reviewM P Rogers, D Dubey, P Reich
Nursing|October 1, 1982
Think fast: what do your know about cardiac drugs for a code? Continuing education creditsR Cantwell, R Hollis, M P Rogers
The American Journal of Psychiatry|August 1, 1983
Conditioned immunosuppression?M P Rogers, J R Peteet, P Reich
Atherosclerosis|September 1, 1976
Effects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetesM P Rogers, D Barnett, D S Robinson
Biochemical Society Symposium|January 1, 1972
The effects of starvation and of cold stress on clearing factor lipase activity and triglyceride fatty acid utilization in rat heartM P Rogers, J Borensztajn, D S Robinson
Journal of Neuro-Oncology|February 24, 2001
Allocentric visuospatial processing in patients with cerebral gliomas: a neurocognitive assessmentV Jagaroo, M P Rogers, P M Black
Atherosclerosis|September 1, 1976
Clearing factor lipase (lipoprotein lipase) activator. A method for the measurement of the net activating ability of human seraM P Rogers, D Barnett, D S Robinson
Journal of Neuro-Oncology|January 31, 2002
The use of a simple Likert scale to measure quality of life in brain tumor patientsM P Rogers, J Orav, P M Black
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Psychosomatics|July 1, 1994
Development of obsessive-compulsive disorder after brain tumor surgery and radiationM P Rogers, A Y Mendoza
FEBS Letters|January 21, 1985
Reconstituted high density lipoprotein behaviour is modified by the nature of the lipid vesicleS M Jones, M P Rogers
Psychosomatic Medicine|March 1, 1979
The influence of the psyche and the brain on immunity and disease susceptibility: a critical reviewM P Rogers, D Dubey, P Reich
Nursing|October 1, 1982
Think fast: what do your know about cardiac drugs for a code? Continuing education creditsR Cantwell, R Hollis, M P Rogers
The American Journal of Psychiatry|August 1, 1983
Conditioned immunosuppression?M P Rogers, J R Peteet, P Reich
Atherosclerosis|September 1, 1976
Effects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetesM P Rogers, D Barnett, D S Robinson
Biochemical Society Symposium|January 1, 1972
The effects of starvation and of cold stress on clearing factor lipase activity and triglyceride fatty acid utilization in rat heartM P Rogers, J Borensztajn, D S Robinson
Journal of Neuro-Oncology|February 24, 2001
Allocentric visuospatial processing in patients with cerebral gliomas: a neurocognitive assessmentV Jagaroo, M P Rogers, P M Black
Atherosclerosis|September 1, 1976
Clearing factor lipase (lipoprotein lipase) activator. A method for the measurement of the net activating ability of human seraM P Rogers, D Barnett, D S Robinson
Journal of Neuro-Oncology|January 31, 2002
The use of a simple Likert scale to measure quality of life in brain tumor patientsM P Rogers, J Orav, P M Black
Pageof 7